Table 4.
Kellgren–Lawrence grade at baseline and at Week 15
Week 15 | Baseline
|
||||
---|---|---|---|---|---|
Grade 1 | Grade 2 | Grade 3 | Grade 4 | ||
Placebo (n=176) | Grade 0 | 0 | 0 | 0 | 0 |
Grade 1 | 9 | 0 | 1 | 0 | |
Grade 2 | 1 | 79 | 4 | 0 | |
Grade 3 | 0 | 4 | 67 | 0 | |
Grade 4 | 0 | 0 | 1 | 8 | |
No observation | 0 | 1 | 1 | 0 | |
Duloxetine (n=178) | Grade 0 | 0 | 0 | 0 | 0 |
Grade 1 | 12 | 2 | 0 | 0 | |
Grade 2 | 2 | 79 | 1 | 0 | |
Grade 3 | 0 | 2 | 67 | 0 | |
Grade 4 | 0 | 0 | 0 | 7 | |
No observation | 0 | 5 | 1 | 0 |
Note: Shading indicates no change in Kellgren–Lawrence grade.